CYREN Stock Forecast, Price & News

+0.01 (+1.60 %)
(As of 04/22/2021 12:00 AM ET)
Today's Range
Now: $0.64
50-Day Range
MA: $0.83
52-Week Range
Now: $0.64
Volume580,595 shs
Average Volume2.14 million shs
Market Capitalization$47.66 million
P/E RatioN/A
Dividend YieldN/A
CYREN Ltd., together with its subsidiaries, provides information security solutions for protecting Web, email, and mobile transactions in the United States, Europe, the Asia Pacific, Israel, and internationally. The company operates Cyren Cloud Security, a SaaS security platform, which provides Internet security services, including Web Security that provides the enforcement of Web policy and state-of-the-art threat protection for business users; DNS Security, which allows businesses to protect employees at headquarters, visitors in remote offices, customers at retail stores, or students on a campus; Email Security, a cloud-based secure email gateway; and Cloud Sandboxing that protects businesses against breaches and data loss from threats. It also operates Cyren Threat Intelligence Services, a platform that offers cloud-based cyber threat detection APIs and SDKs to technology and security vendors. The company's threat intelligence services comprise embedded email and Web security services; Endpoint Security, which detects malware on various endpoints, including mobile devices and embedded operating system devices; and advanced threat protection services, such as tools for combating mobile malware, ransomware, and other Web-borne threats. CYREN Ltd. sells its products through direct and indirect channels, including value added resellers and managed service providers to enterprise customers and original equipment manufacturers. The company was formerly known as Commtouch Software Ltd. and changed its name to CYREN Ltd. in January 2014. CYREN Ltd. was founded in 1991 and is headquartered in McLean, Virginia. CYREN Ltd. is a subsidiary of WP XII Investments B.V.
CYREN logo

Industry, Sector and Symbol

Industry Prepackaged software
Current SymbolNASDAQ:CYRN
Year FoundedN/A



Sales & Book Value

Annual Sales$38.39 million
Book Value$0.42 per share


Net Income$-18,020,000.00


Market Cap$47.66 million
Next Earnings Date5/12/2021 (Estimated)
OptionableNot Optionable


CYREN Ltd. (NASDAQ:CYRN) Short Interest Update
April 18, 2021 |
CYREN Ltd. to Host Earnings Call - Yahoo Finance
February 22, 2021 |
Earnings Outlook For CYREN - Benzinga
February 19, 2021 |
Earnings Outlook For CYREN - Yahoo Finance
February 19, 2021 |
Earnings Outlook For CYREN
February 19, 2021 |
See More Headlines


Overall MarketRank

0.85 out of 5 stars

Computer And Technology Sector

770th out of 1,554 stocks

Prepackaged Software Industry

177th out of 283 stocks

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
+0.01 (+1.60 %)
(As of 04/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CYRN News and Ratings via Email

Sign-up to receive the latest news and ratings for CYRN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

CYREN (NASDAQ:CYRN) Frequently Asked Questions

What stocks does MarketBeat like better than CYREN?

Wall Street analysts have given CYREN a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but CYREN wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting CYREN?

CYREN saw a decrease in short interest in March. As of March 31st, there was short interest totaling 510,400 shares, a decrease of 24.3% from the March 15th total of 673,800 shares. Based on an average daily volume of 2,350,000 shares, the days-to-cover ratio is currently 0.2 days. Approximately 1.3% of the company's stock are short sold.
View CYREN's Short Interest

When is CYREN's next earnings date?

CYREN is scheduled to release its next quarterly earnings announcement on Wednesday, May 12th 2021.
View our earnings forecast for CYREN

How were CYREN's earnings last quarter?

CYREN Ltd. (NASDAQ:CYRN) announced its quarterly earnings data on Sunday, February, 21st. The technology company reported ($0.06) earnings per share for the quarter, meeting the consensus estimate of ($0.06). The technology company had revenue of $8.44 million for the quarter. CYREN had a negative net margin of 46.96% and a negative trailing twelve-month return on equity of 79.16%.
View CYREN's earnings history

How has CYREN's stock price been impacted by Coronavirus (COVID-19)?

CYREN's stock was trading at $0.95 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CYRN stock has decreased by 33.1% and is now trading at $0.6360.
View which stocks have been most impacted by COVID-19

What guidance has CYREN issued on next quarter's earnings?

CYREN issued an update on its fourth quarter 2020 IntraDay earnings guidance on Thursday, February, 11th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $8.4-8.4 million, compared to the consensus revenue estimate of $8.96 million.

Who are CYREN's key executives?

CYREN's management team includes the following people:
  • Mr. Brett M. Jackson, CEO & Director (Age 60, Pay $264.6k)
  • Dr. Richard Anthony Ford, Chief Technology Officer (Age 51, Pay $352.24k)
  • Mr. Lior Kohavi, Chief Strategy Officer & Exec. VP of Advanced Solutions (Age 50, Pay $333.51k)
  • Mr. Kenneth J. Tarpey, Chief Financial Officer, (Age 68)
  • Mr. Daniel S. Maier, VP of Marketing (Age 57)
  • Ms. Eva Edwards Markowitz, VP of HR (Age 46)
  • Mr. Dominick David DiPietro, VP of Sales - North America (Age 56)

Who are some of CYREN's key competitors?

What other stocks do shareholders of CYREN own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CYREN investors own include Actinium Pharmaceuticals (ATNM), Inovio Pharmaceuticals (INO), Onconova Therapeutics (ONTX), OPKO Health (OPK), Vaxart (VXRT), Biocept (BIOC), iBio (IBIO), MEI Pharma (MEIP), VBI Vaccines (VBIV) and Ampio Pharmaceuticals (AMPE).

What is CYREN's stock symbol?

CYREN trades on the NASDAQ under the ticker symbol "CYRN."

How do I buy shares of CYREN?

Shares of CYRN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CYREN's stock price today?

One share of CYRN stock can currently be purchased for approximately $0.64.

How much money does CYREN make?

CYREN has a market capitalization of $47.66 million and generates $38.39 million in revenue each year.

How many employees does CYREN have?

CYREN employs 222 workers across the globe.

What is CYREN's official website?

The official website for CYREN is

Where are CYREN's headquarters?

CYREN is headquartered at 10 Ha-Menofim St. 5th Floor, Herzliya L3, 4672561.

How can I contact CYREN?

CYREN's mailing address is 10 Ha-Menofim St. 5th Floor, Herzliya L3, 4672561. The technology company can be reached via phone at 972-9863-6888 or via email at [email protected]

This page was last updated on 4/22/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.